HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity # †
Hepatology2009Vol. 50(1), pp. 94–101
Citations Over TimeTop 10% of 2009 papers
Lyle C. Gurrin, Nadine A. Bertalli, Gregory W. Dalton, Nicholas J. Osborne, Clare C. Constantine, Christine E. McLaren, Dallas R. English, Dorota M. Gertig, Martin B. Delatycki, Amanda Nicoll, Melissa C. Southey, John L. Hopper, Graham G. Giles, Gregory J. Anderson, John K. Olynyk, Lawrie W. Powell, Katrina J. Allen
Abstract
For male compound heterozygotes, mean iron indices do not change during middle age but for female compound heterozygotes menopause results in increased mean SF. Although compound heterozygotes might maintain elevated iron indices during middle age, documented iron overload-related disease is rare.
Related Papers
- → Hereditary Hemochromatosis: Missed Diagnosis or Misdiagnosis?(2013)18 cited
- Hereditary hemochromatosis: a case study and review.(2001)
- Non HFE related hereditary haemochromatosis.(2014)
- [Molecular basis of hereditary hemochromatosis].(2006)
- → Crohn’s Disease and Hereditary Hemochromatosis, a Case Report(2021)